Phase I Study of Inotuzumab With Augmented BFM Re-Induction for Younger Adults With Relapsed/Refractory B-cell ALL

Condition:   B-cell Acute Lymphoblastic Leukemia Interventions:   Drug: Inotuzumab ozogamicin;   Drug: Prednisone Pill;   Drug: Daunorubicin;   Drug: Vincristine;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Pegaspargase Sponsors:   University of Virginia;   Pfizer;   Vanderbilt University;   University of Wisconsin, Madison;   Virginia Commonwealth University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials